Tom Broockmann, Medical Cannabis Expert: "Producing Cannabis Is Not So Simple, We Lack Expertise in Europe"
As 2025 marks significant growth in the German therapeutic cannabis market, questions arise about import models, the application of European standards, and access to prescriptions. Tom Broockmann, director of Adrex Pharma, a German company specializing in medical cannabis marketing, provides insights to better understand the German and European markets that still struggle to compete economically with Canadian players.
Aurore Dupont - 4 June 2026
Read more